Furthermore, since brain NAD+ level can be increased by administration of NAD+ precursors such as nicotinamide riboside and nicotinamide mononucleotide (Gong et al., 2013), it will be intriguing to test these molecules in CPZ-induced demyelination model. The gene discussed is CPZ; the disease is Peripheral demyelination.